FDA’s Push for 'Radical Transparency'

Drug developers and inventors of new drugs are trying to figure out how do they get through this long, gnarly regulatory process. Well, we can be more transparent. We can provide better communications. We can provide guidance. We can answer questions on demand.And we are announcing that we're going to make our decision letters public so that drug developers can see why drugs are not accepted at the FDA. Why weren't they public. Some of the drug companies don't want them public.We learned that most companies ...